SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $343,438 | +1.0% | 350,000 | 0.0% | 0.00% | – |
| Q3 2022 | $340,000 | +0.3% | 350,000 | 0.0% | 0.00% | – |
| Q2 2022 | $339,000 | -2.0% | 350,000 | 0.0% | 0.00% | – |
| Q1 2022 | $346,000 | -0.6% | 350,000 | 0.0% | 0.00% | – |
| Q4 2021 | $348,000 | +0.9% | 350,000 | 0.0% | 0.00% | – |
| Q3 2021 | $345,000 | -0.6% | 350,000 | 0.0% | 0.00% | – |
| Q2 2021 | $347,000 | +2.4% | 350,000 | 0.0% | 0.00% | – |
| Q1 2021 | $339,000 | +2.7% | 350,000 | 0.0% | 0.00% | – |
| Q4 2020 | $330,000 | +2.2% | 350,000 | 0.0% | 0.00% | – |
| Q3 2020 | $323,000 | +3.9% | 350,000 | 0.0% | 0.00% | – |
| Q2 2020 | $311,000 | +9.9% | 350,000 | 0.0% | 0.00% | – |
| Q1 2020 | $283,000 | -11.0% | 350,000 | 0.0% | 0.00% | – |
| Q4 2019 | $318,000 | -2.5% | 350,000 | 0.0% | 0.00% | – |
| Q3 2019 | $326,000 | -51.0% | 350,000 | -50.0% | 0.00% | – |
| Q2 2019 | $665,000 | – | 700,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|